Equitec Proprietary Markets, LLC Precigen, Inc. Call Options Transaction History

Equitec Proprietary Markets, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 Apr 22, 2022	SELL	$1.91 - $3.98 $14,134 - $29,452	-7,400 Closed	0 $0
Q4 2021 Jan 31, 2022	SELL	$3.53 - $5.5 $14,120 - $22,000	-4,000 Reduced 35.09%	7,400 $27,000
Q3 2021 Oct 12, 2021	SELL	$4.99 - $6.55 $38,922 - $51,090	-7,800 Reduced 40.63%	11,400 $57,000
Q2 2021 Jul 20, 2021	SELL	$6.24 - $8.22 $81,744 - $107,682	-13,100 Reduced 40.56%	19,200 $125,000
Q4 2020 Jan 26, 2021	BUY	$3.75 - $10.56 $90,375 - $254,496	24,100 Added 293.9%	32,300 $329,000
Q3 2020 Oct 13, 2020	SELL	$3.5 - $6.2 $70,000 - $124,000	-20,000 Reduced 70.92%	8,200 $29,000
Q1 2020 Apr 19, 2021	BUY	$1.46 - $7.19 $41,172 - $202,758	28,200 New	28,200 $194,000

143

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $179M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Equitec Proprietary Markets, LLC, based on Form 13F filings with the SEC.

Stay updated on Equitec Proprietary Markets, LLC with notifications on news.